Exploring CBTi's Dual Effect on Sleep, Diet, & Chrononutrition
- Disease/Condition
- Insomnia
- Drug/Device/Intervention
- Cognitive Behavioral Therapy for Insomnia (CBT-i)
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- American University of Beirut Medical Center
- Location
- Jbaïl,Beirut, Lebanon
- Phase
- N/A
- Start date
- Nov 11, 2022
- End date
- Jan 01, 2025
- Enrollment
- 40 participants
Change in Bed Time,Change in Get Up Time,Change in Time in Bed,Change in Sleep Onset Latency (in minutes).,Change in Sleep Efficiency,Change in Wake After Sleep Onset,Change in Late-Night Eating Occasions number,Change in Eating Window Duration and Fasting Window Duration,Change in Number of Meals
This study aims to investigate the effects of Cognitive Behavioral Therapy for Insomnia
 (CBTi) on both sleep patterns and dietary habits in Lebanese adults with insomnia. Sleep
 patterns and dietary habits are intricately linked, with dysregulated sleep associated with
 poor diet quality and increased snacking. Conversely, the types of nutrients consumed can
 affect hormonal balance and circadian rhythm. Insomnia and obesity are interrelated public
 health concerns, with CBTi showing efficacy in improving sleep. This study will recruit
 participants with insomnia and randomly assign them to receive either CBTi or basic sleep
 hygiene education. Baseline assessments will include validated questionnaires about insomnia,
 dietary habits, and physical activity and a 7-day 24-hour diet recall sheets, as well as
 actigraphy for sleep parameters, and physical activity assessments. The intervention will
 last for four weeks, with post-intervention assessments conducted similarly to baseline.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06300684
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06300684 through Pure Global AI's free database. This phase not specified trial is sponsored by American University of Beirut Medical Center and is currently Recruiting. The study focuses on Insomnia. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.